T Trenque

Summary

Country: France

Publications

  1. doi request reprint Reports of sexual disorders related to serotonin reuptake inhibitors in the French pharmacovigilance database: an example of underreporting
    Thierry Trenque
    Regional Centre for Pharmacovigilance and Pharmacoepidemiology, Reims University Teaching Hospitals, avenue du Général Koenig, 51092 Reims, France
    Drug Saf 36:515-9. 2013
  2. doi request reprint Serotonin reuptake inhibitors and hyperprolactinaemia: a case/non-case study in the French pharmacovigilance database
    Thierry Trenque
    Regional Center for Pharmacovigilance and Pharmacoepidemiology, Reims University Hospitals, France
    Drug Saf 34:1161-6. 2011
  3. ncbi request reprint Reports of withdrawal syndrome with the use of SSRIs: a case/non-case study in the French Pharmacovigilance database
    T Trenque
    Regional Pharmacovigilance Centre Champagne Ardenne, Centre Hospitalier Universitaire, 45 rue Cognacq Jay, 51092 Reims, France
    Pharmacoepidemiol Drug Saf 11:281-3. 2002
  4. pmc Population pharmacokinetics of pyrimethamine and sulfadoxine in children with congenital toxoplasmosis
    T Trenque
    Laboratoire de Pharmacologie Toxicologie, CHU, Reims, France
    Br J Clin Pharmacol 57:735-41. 2004
  5. ncbi request reprint [Development of antidepressant drugs. Experience and prospects]
    Nicolas Bouvier
    Laboratoire de Pharmacologie Toxicologie, Hopital Maison Blanche, CHU, 45, rue Cognacq Jay 51092 Reims
    Presse Med 32:519-22. 2003
  6. ncbi request reprint [Iatrogenic risk of self-medication by the pregnant patient]
    N Bouvier
    Laboratoire de Pharmacologie-Toxicologie, , CHU, Reims
    Presse Med 30:37-40. 2001
  7. ncbi request reprint [Utilization of methylphenidate(Ritalin) in France]
    C Frances
    Centre Regional de Pharmacovigilance, Laboratoire de Pharmacologie et de Toxicologie, Reims, France
    Therapie 57:189-93. 2002
  8. ncbi request reprint Gas chromatographic determination of meprobamate in human plasma
    T Trenque
    Laboratoire de Pharmacologie et de Toxicologie, Centre Hospitalier Regional et Universitaire, Reims, France
    J Chromatogr 615:343-6. 1993
  9. pmc Paediatric methylphenidate (Ritalin) restrictive conditions of prescription in France
    C Frances
    Br J Clin Pharmacol 57:115-6. 2004
  10. ncbi request reprint [Prenatal treatment of congenital toxoplasmosis]
    C Chemla
    Presse Med 34:1719. 2005

Collaborators

Detail Information

Publications11

  1. doi request reprint Reports of sexual disorders related to serotonin reuptake inhibitors in the French pharmacovigilance database: an example of underreporting
    Thierry Trenque
    Regional Centre for Pharmacovigilance and Pharmacoepidemiology, Reims University Teaching Hospitals, avenue du Général Koenig, 51092 Reims, France
    Drug Saf 36:515-9. 2013
    ..In pharmacoepidemiological studies, sexual disorders are reported by more than 50 % of patients taking serotonin reuptake inhibitors (SRIs)...
  2. doi request reprint Serotonin reuptake inhibitors and hyperprolactinaemia: a case/non-case study in the French pharmacovigilance database
    Thierry Trenque
    Regional Center for Pharmacovigilance and Pharmacoepidemiology, Reims University Hospitals, France
    Drug Saf 34:1161-6. 2011
    ..Serotonin reuptake inhibitors (SRIs) are reportedly associated with hyperprolactinaemia; however, the number of published cases in the literature is limited...
  3. ncbi request reprint Reports of withdrawal syndrome with the use of SSRIs: a case/non-case study in the French Pharmacovigilance database
    T Trenque
    Regional Pharmacovigilance Centre Champagne Ardenne, Centre Hospitalier Universitaire, 45 rue Cognacq Jay, 51092 Reims, France
    Pharmacoepidemiol Drug Saf 11:281-3. 2002
    ..16, 95% CI: 6.17-23.35 and OR: 8.47, 95% CI: 5.63-12.65, respectively). The risk of withdrawal reactions appears to be greater with short half-life drugs such as paroxetine and venlafaxine. The precise mechanisms have not been identified...
  4. pmc Population pharmacokinetics of pyrimethamine and sulfadoxine in children with congenital toxoplasmosis
    T Trenque
    Laboratoire de Pharmacologie Toxicologie, CHU, Reims, France
    Br J Clin Pharmacol 57:735-41. 2004
    ..To develop a population pharmacokinetic model for pyrimethamine (PYR) and sulfadoxine (SDX) in children with congenital toxoplasmosis...
  5. ncbi request reprint [Development of antidepressant drugs. Experience and prospects]
    Nicolas Bouvier
    Laboratoire de Pharmacologie Toxicologie, Hopital Maison Blanche, CHU, 45, rue Cognacq Jay 51092 Reims
    Presse Med 32:519-22. 2003
    ..The complexity of the physiopathological mechanisms of depression hence appears enhanced...
  6. ncbi request reprint [Iatrogenic risk of self-medication by the pregnant patient]
    N Bouvier
    Laboratoire de Pharmacologie-Toxicologie, , CHU, Reims
    Presse Med 30:37-40. 2001
    ..The specific features of disease during pregnancy should be considered when giving relevant information...
  7. ncbi request reprint [Utilization of methylphenidate(Ritalin) in France]
    C Frances
    Centre Regional de Pharmacovigilance, Laboratoire de Pharmacologie et de Toxicologie, Reims, France
    Therapie 57:189-93. 2002
    ....
  8. ncbi request reprint Gas chromatographic determination of meprobamate in human plasma
    T Trenque
    Laboratoire de Pharmacologie et de Toxicologie, Centre Hospitalier Regional et Universitaire, Reims, France
    J Chromatogr 615:343-6. 1993
    ..The method is accurate (97.7 +/- 5.7% at 20 mg/l) and precise (maximum coefficient of variation of 9.5%). It provides an alternative to existing methods and is particularly suitable for toxicological studies...
  9. pmc Paediatric methylphenidate (Ritalin) restrictive conditions of prescription in France
    C Frances
    Br J Clin Pharmacol 57:115-6. 2004
  10. ncbi request reprint [Prenatal treatment of congenital toxoplasmosis]
    C Chemla
    Presse Med 34:1719. 2005
  11. ncbi request reprint Bromism from daily over intake of bromide salt
    C Frances
    Centre Regional de Pharmacovigilance, Hopital Maison Blanche, CHU de Reims, France
    J Toxicol Clin Toxicol 41:181-3. 2003
    ..This case demonstrates that, while today bromism occurs infrequently, it should still be included in the differential diagnosis of neuropsychiatric symptoms...